(Q34392982)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11588700%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Travel vaccines and elderly persons: review of vaccines available in the United States (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11588700%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11588700%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Weller PF

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11588700%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Wilson ME

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11588700%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

4 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11588700%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11588700%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11588700%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11588700%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

1553-1566

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11588700%20AND%20SRC:MED&resulttype=core&format=json

The immunology of exceptional individuals: the lesson of centenarians.

11 November 2019

cites work

1 reference

Immune senescence: mechanisms and clinical implications

21 January 2018

1 reference

A cumulative review of studies on travellers, their experience of illness and the implications of these findings

21 January 2018

1 reference

Hepatitis A and hepatitis B: risks compared with other vaccine preventable diseases and immunization recommendations

21 January 2018

1 reference

Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.

21 January 2018

1 reference

Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study

21 January 2018

1 reference

Immunoglobulin prophylaxis for hepatitis A

21 January 2018

1 reference

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

21 January 2018

1 reference

Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule).

21 January 2018

1 reference

Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later

21 January 2018

1 reference

Immunogenicity of an inactivated hepatitis A vaccine in Dutch United Nations troops

21 January 2018

1 reference

The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults

21 January 2018

1 reference

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview

21 January 2018

1 reference

Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults.

21 January 2018

1 reference

Simultaneous active and passive immunization against hepatitis A studied in a population of travellers

21 January 2018

1 reference

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

21 January 2018

1 reference

Clinical trial with inactivated hepatitis A vaccine and recommendations for its use

21 January 2018

1 reference

Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance

21 January 2018

1 reference

Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise

21 January 2018

1 reference

Typhoid in the United States and the Risk to the International Traveler

21 January 2018

1 reference

Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines

21 January 2018

1 reference

Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization

21 January 2018

1 reference

A new typhoid vaccine composed of the Vi capsular polysaccharide

21 January 2018

1 reference

Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines

21 January 2018

1 reference

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever

21 January 2018

1 reference

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report

21 January 2018

1 reference

Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity

21 January 2018

1 reference

Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid fever

21 January 2018

1 reference

Imported yellow fever in a United States citizen

21 January 2018

1 reference

A haemorrhagic fever from the Côte d'Ivoire

21 January 2018

1 reference

Anaphylaxis from yellow fever vaccine

21 January 2018

1 reference

Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations

21 January 2018

1 reference

21 January 2018

Yellow fever vaccines

1 reference

Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccines

21 January 2018

1 reference

Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination

21 January 2018

1 reference

21 January 2018

Travel-related vaccines

1 reference

Immunisation against Japanese encephalitis

21 January 2018

1 reference

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

21 January 2018

1 reference

A Cluster of Severe Reactions Following Improperly Administered Takeda Japanese Encephalitis Vaccine

21 January 2018

1 reference

Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination

21 January 2018

1 reference

Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains).

21 January 2018

1 reference

Neurological complications to vaccination against Japanese encephalitis

21 January 2018

1 reference

Side-effects with Japanese encephalitis vaccine

21 January 2018

1 reference

Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine

21 January 2018

1 reference

Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants

21 January 2018

1 reference

Further experience with Japanese encephalitis vaccine

21 January 2018

1 reference

Immunisation against Japanese Encephalitis in Nepal: Experience of 1152 subjects

21 January 2018

1 reference

Protection against Japanese encephalitis by inactivated vaccines

21 January 2018

1 reference

Case-control study of allergic reactions to Japanese encephalitis vaccine

21 January 2018

1 reference

Antibody responses to human diploid cell vaccine for rabies with and without human rabies immune globulin.

21 January 2018

1 reference

21 January 2018

Modern vaccines. Rabies

1 reference

Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine

21 January 2018

1 reference

A global review of rabies vaccines for human use.

21 January 2018

1 reference

Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization

21 January 2018

1 reference

Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers

21 January 2018

1 reference

Immunization with a human diploid cell strain of rabies virus vaccine: two-year results

21 January 2018

1 reference

Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy.

21 January 2018

1 reference

Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationwide prospective study

21 January 2018

1 reference

Combined vaccination against yellow fever and typhoid fever: a comparative trial

21 January 2018

1 reference

Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization.

21 January 2018

1 reference

Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever

21 January 2018

1 reference

Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation

21 January 2018

1 reference

Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee

21 January 2018

1 reference

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine

21 January 2018

1 reference

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

21 January 2018

1 reference

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine

21 January 2018

1 reference

A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results

21 January 2018

1 reference

The human humoral immune response to Salmonella typhi Ty21a.

21 January 2018

1 reference

Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series

21 January 2018

1 reference

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

21 January 2018

1 reference

Protection against hepatitis A by an inactivated vaccine

21 January 2018

1 reference